Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
Diane M. Demas, Susan D. Demo, Yassi Fallah, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
Ellen C. de Heer, Mathilde Jalving, Adrian L. Harris
Journal of Clinical Investigation (2020) Vol. 130, Iss. 10, pp. 5074-5087
Open Access | Times Cited: 277
Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
Cedric Magaway, Eugene Kim, Estela Jacinto
Cells (2019) Vol. 8, Iss. 12, pp. 1584-1584
Open Access | Times Cited: 191
Glutamine metabolism in breast cancer and possible therapeutic targets
Shiqi Li, Hui Zeng, Junli Fan, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115464-115464
Closed Access | Times Cited: 54
Metabolic Plasticity in Chemotherapy Resistance
María Andrea Desbats, Isabella Giacomini, Tommaso Prayer‐Galetti, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 135
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Jiaqi Li, Jie Qing Eu, Li Kong, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4831-4831
Open Access | Times Cited: 106
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
Matteo Morotti, Christos E. Zois, Rokaya El Ansari, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 2, pp. 494-505
Open Access | Times Cited: 89
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 89
Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies
Özge Saatci, Kim‐Tuyen Huynh‐Dam, Özgür Şahin
Journal of Molecular Medicine (2021) Vol. 99, Iss. 12, pp. 1691-1710
Open Access | Times Cited: 82
M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62
Ke Zhang, Yujie Li, Linjia Peng, et al.
Biology Direct (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 28
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance
Chandrima Das, Apoorva Bhattacharya, Swagata Adhikari, et al.
Oncogene (2024) Vol. 43, Iss. 23, pp. 1727-1741
Open Access | Times Cited: 10
Mitochondrial inhibitors: a new horizon in breast cancer therapy
Yalan Yan, Sijie Li, Lanqian Su, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer
Karthik Reddy Kami Reddy, Danthasinghe Waduge Badrajee Piyarathna, Jun Hyoung Park, et al.
JCI Insight (2024) Vol. 9, Iss. 17
Open Access | Times Cited: 6
Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer
Thomas N. Seyfried, Purna Mukherjee, M. S. Iyikesici, et al.
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 42
HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis
Xiaowen Chen, Yixin Chen, Min Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Metabolomic rewiring promotes endocrine therapy resistance in breast cancer
Songyeon Ahn, Jun Hyoung Park, Sandra L. Grimm, et al.
Cancer Research (2023) Vol. 84, Iss. 2, pp. 291-304
Open Access | Times Cited: 13
Relationship between metabolic reprogramming and drug resistance in breast cancer
Linlin Lv, Shilei Yang, Yanna Zhu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness
Karla Andrade de Oliveira, Surojeet Sengupta, Anil Yadav, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12
Triple-positive breast cancer: navigating heterogeneity and advancing multimodal therapies for improving patient outcomes
Jie Xie, Zhihui Yang, Zhuolin Li, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Proposed Comprehensive Methodology Integrated with Explainable Artificial Intelligence for Prediction of Possible Biomarkers in Metabolomics Panel of Plasma Samples for Breast Cancer Detection
Cemil Çolak, Fatma Hilal Yağın, Abdulmohsen Algarni, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 581-581
Open Access
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer
Ayodeji Olukoya, Hillary Stires, Shaymaa Bahnassy, et al.
Journal of the Endocrine Society (2023) Vol. 7, Iss. 10
Open Access | Times Cited: 10
Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK1
Guangzhao Zhu, Fangxia Guan, Shenglei Li, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 897-911
Closed Access | Times Cited: 3
Therapeutic strategies targeting metabolic characteristics of cancer cells
Rilan Bai, Ying Meng, Jiuwei Cui
Critical Reviews in Oncology/Hematology (2023) Vol. 187, pp. 104037-104037
Open Access | Times Cited: 8
The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
Jie Yuan, Yang Li, Zhi Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 7
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics
Tatiana J. Carneiro, Ana L. M. Batista de Carvalho, Martin Vojtek, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
NEDD4L inhibits cell viability, cell cycle progression, and glutamine metabolism in esophageal squamous cell carcinoma via ubiquitination of c-Myc
Wei Cheng, Guiyuan Li, Ye Zhou, et al.
Acta Biochimica et Biophysica Sinica (2022) Vol. 54, Iss. 5, pp. 716-724
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top